LY333531 [ruboxistaurin] treatment of peripheral neuropathy in patients with diabetes
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Ruboxistaurin (Primary)
- Indications Diabetic neuropathies
- Focus Registrational; Therapeutic Use
- 30 Oct 2006 Status change
- 16 Oct 2005 New trial record.